Global Fetal and Neonatal Care Equipment Market - Insights
Fetal and neonatal care products are used for assessment and treatment of newborn babies. Fetal care equipment include devices, which help in monitoring and diagnosis of both mother and fetus. Equipment, which help in assisting in diagnosis, monitoring or treatment of newborn babies are neonatal care equipment. According to the UN Foundation, 2015, maternal & infant care is a global priority, as around 800 women die every day from preventable causes associated with pregnancy or childbirth. This has led to increasing demand for neonatal and fetal care equipment.
The global fetal and neonatal care equipment market is estimated to be valued at US$ 7,279.5 million in 2017 and is expected to witness a CAGR of 7.4% over the forecast period (2017 – 2025).
Figure 1. Global Fetal and Neonatal Care Equipment Market Value (US$ Mn) Analysis and Forecast and Absolute $ Opportunity (US$ Mn)
Source: Coherent Market Insights Analysis (2017)
Increasing government initiatives for fetal and neonatal care is expected for growth of the market
Various government and non-government organizations are actively taking initiatives to provide better maternal and fetal care. Moreover, rise in number of problems during pregnancy due to high-blood pressure, diabetes, preterm labor affects the fetus. So, fetal and neonatal care devices are routinely used by gynecologist and obstetrics to examine fetal or babies’ health during labor and delivery. According to National Institute of Health, Newborn screening programs across the U.S., screen four million infants each year. This public health program detects treatable disorders in newborns, allowing treatment to begin, often before symptoms or permanent problems. Furthermore, demand for fetal monitoring devices is also increasing significantly to reduce intrapartum stillbirths. According to WHO, annually, 15 million babies are born preterm, of which 1 million died before the age of five years, as stated in 2015.
North America is expected to account for highest market share in the global fetal and neonatal care equipment market, owing to the presence of a better reimbursement structure, development of well-equipped neonatal intensive care unit by hospitals. The Newborn Intensive Care Unit (NICU) at Brigham and Women’s Hospital (BWH) is a 60-bed Level III newborn intensive care unit that provides complex multidisciplinary care to more than 3,000 babies each year. Moreover, Asia Pacific is expected to witness high growth in the global fetal and neonatal care equipment market. This is owing to increasing incidences of premature births, high birth rates in countries such as India and China, and increasing healthcare awareness are the factors boosting growth of the market in this region. According to WHO, 2012, most neonatal deaths occur in Asia, which accounted for 40% of the global neonatal deaths, given the high mortality rate in the South-central Asia sub-region. Furthermore, neonatal equipment has been observed to have increasing demand in the middle-income countries, as birth rates in these countries are higher, and the priority for improved fetal & neonatal care is high in these countries. As a result, sales of the equipment are expected to flourish at a rapid rate.
Key players in the region are focusing on offering clinicians, innovative tools and devices for enhancing safety for mothers, babies, and families. For this, companies are focusing on acquisition strategy and increasing regulatory approval for the devices. For instance, in March, 2017, GE Healthcare expanded its Maternal-Infant Care business with the acquisition of Monica Healthcare — a U.K.-based monitoring technology company. This acquisition enhances GE Healthcare’s mobile and digital offerings by providing clinicians and patients around the world with more innovative solutions for labor, delivery, and home care. Furthermore, in February, 2017, Masimo received CE marking for Eve — a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97 Pulse CO-Oximeter. Eve is integrated with Masimo SET Measure-through Motion and Low Perfusion pulse oximetry with a pre-ductal to post-ductal synchronization algorithm designed to reduce calculation errors and giving appropriate outcomes for the treatment of newborn lives.
Key players operating in the global fetal and neonatal care equipment market include Koninklijke Philips N.V., General Electric Company, Medtronic plc, Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited., FUJIFILM SonoSite, Inc., Masimo, Natus Medical Incorporated, Atom Medical Corporation, and CooperSurgical Inc.